Skip to content

David Baxley Spetzler, President at Caris Life Sciences, sold CAI on Sep 3, 2026

Data as of Oct 16

▼ SELL$9.7M393,100 shares at $24.76David Baxley Spetzler PresidentCAI Caris Life Sciences, Inc.
Watch CAI
Traded
Sep 3, 2026
Disclosed
Sep 4, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

David Baxley Spetzler, President at Caris Life Sciences, sold CAI on Sep 3, 2026TRADEDDISCLOSED
CAISimilar stocks (XLV — its sector index fund), rebased to CAI's price on the disclosure day
CAI since disclosure
+21.9%
after the sale
Similar stocks (XLV) since disclosure
+3.1%
XLV — its sector index fund

Change in closing price from Sep 4, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLDavid Baxley Spetzler PresidentCAI Caris Life Sciences, Inc.$3Mdisclosed Sep 4 · filed the same day
  2. ▼ SELLDavid Baxley Spetzler PresidentCAI Caris Life Sciences, Inc.$2.1Mdisclosed Sep 4 · filed 1 day after the trade

See every trade on CAI →